COEP - התחייבויות לטווח ארוך של החברה Coeptis Therapeutics
This daily price chart for Coeptis Therapeutics (COEP) illustrates the dynamics of debt obligations, which currently stand at 0.00. Coeptis Therapeutics (COEP) is utilizing its existing reserves to drive innovation, as commercial revenue is currently absent. The business is implementing automation in NK-cell cultivation to eliminate human error risk. The enterprise's success depends on medical trial results and access to venture capital for the development of cellular technologies.
Coeptis Therapeutics, Inc. (COEP) - פילוחי מדדים ודוחות פיננסיים
Fundamental asset selection requires strict control of debt load to assess the issuer's financial stability. This indicator aggregates confirmed loan and bond obligations with maturities exceeding one year, allowing for an assessment of the cost of bioscreening robotization at Coeptis Therapeutics (COEP) through the business's current level of long-term borrowed capital.